| no |
title |
author |
magazine |
year |
volume |
issue |
page(s) |
type |
| 1 |
Adjuvant and neoadjuvant treatment of melanoma
|
Koelblinger, Peter
|
|
|
13 |
3 |
p. 301-305
|
article
|
| 2 |
ASH highlights 2019: “aggressive B-cell lymphoma”
|
Schmitt, Clemens A.
|
|
|
13 |
3 |
p. 266-269
|
article
|
| 3 |
Biologically effective dose and overall survival in stereotactic body radiotherapy for lung tumors
|
Tanaka, Osamu
|
|
|
13 |
3 |
p. 353-356
|
article
|
| 4 |
Chemoradiotherapy alone or chemoradiotherapy followed by surgery in rectal cancer
|
Lunger, Fabian
|
|
|
13 |
3 |
p. 324-328
|
article
|
| 5 |
Circulating tumour DNA-guided adjuvant chemotherapy in colorectal carcinoma
|
Reichinger, Andreas
|
|
|
13 |
3 |
p. 334-336
|
article
|
| 6 |
Comparison of outcomes of two non-BCNU-containing conditioning regimens used in autologous stem cell transplantation for relapsed/refractory lymphoma
|
El-Ghammaz, Amro Mohamed Sedky
|
|
|
13 |
3 |
p. 294-300
|
article
|
| 7 |
Creating the “new normal” post-Coronavirus world—web-communication replacing face-to-face interaction
|
Hilbe, Wolfgang
|
|
|
13 |
3 |
p. 245-246
|
article
|
| 8 |
Fine-tuning front-line therapy in chronic lymphocytic leukemia
|
Bohn, Jan-Paul
|
|
|
13 |
3 |
p. 259-265
|
article
|
| 9 |
Four lines of immunochemotherapy combinations in a young patient with an aggressive metastatic colorectal cancer
|
Witte, Frédéric H.
|
|
|
13 |
3 |
p. 337-340
|
article
|
| 10 |
Highlights of ASH 2019—multiple myeloma
|
Ludwig, Heinz
|
|
|
13 |
3 |
p. 270-275
|
article
|
| 11 |
Managing an oncology clinic during the COVID-19 pandemic—how we did it in Sarajevo?
|
Beslija, Semir
|
|
|
13 |
3 |
p. 255-256
|
article
|
| 12 |
memo—publisher’s report 2019
|
Sillaber, Alois
|
|
|
13 |
3 |
p. 257-258
|
article
|
| 13 |
Myeloid diseases—Chronic Myeloid Leukemia (CML)—report from ASH 2019 on new developments
|
Petzer, Andreas L.
|
|
|
13 |
3 |
p. 276-279
|
article
|
| 14 |
Neoadjuvant chemoradiotherapy in rectal cancer
|
Arnold, Christoph Reinhold
|
|
|
13 |
3 |
p. 329-333
|
article
|
| 15 |
News from ASH 2019
|
Gunsilius, Eberhard
|
|
|
13 |
3 |
p. 247-248
|
article
|
| 16 |
New systemic treatment options in mycosis fungoides and Sézary syndrome
|
Seidl-Philipp, Magdalena
|
|
|
13 |
3 |
p. 280-284
|
article
|
| 17 |
Patient-reported outcomes and psycho-oncological screening in hematology: a practical example of routine electronic monitoring
|
Lehmann, Jens
|
|
|
13 |
3 |
p. 285-293
|
article
|
| 18 |
Rectal cancer among younger Egyptian patients—clinico-pathological features and oncologic outcomes: A single institution experience
|
Zaid, Amir M.
|
|
|
13 |
3 |
p. 314-323
|
article
|
| 19 |
Rectal cancer: latest developments and innovative new treatment concepts
|
Amann, Arno
|
|
|
13 |
3 |
p. 251-252
|
article
|
| 20 |
San Antonio Breast Cancer Symposium 2019: human epidermal growth factor receptor 2(HER2)-positive breast cancer and image-guided biopsy to detect pathologic complete response (pCR)
|
Dormann, Clemens
|
|
|
13 |
3 |
p. 341-345
|
article
|
| 21 |
San Antonio 2019: interesting topics for daily clinical practice in breast cancer
|
Galid, Arik
|
|
|
13 |
3 |
p. 349-352
|
article
|
| 22 |
The future of combination therapies in advanced melanoma
|
Hoeller, Christoph
|
|
|
13 |
3 |
p. 309-313
|
article
|
| 23 |
Therapies in flux: highlights of the 2019 San Antonio Breast Cancer Symposium (SABCS)
|
Gampenrieder, Simon Peter
|
|
|
13 |
3 |
p. 253-254
|
article
|
| 24 |
The therapeutic landscape of advanced melanoma
|
Richtig, Erika
|
|
|
13 |
3 |
p. 306-308
|
article
|
| 25 |
Treatment of advanced melanoma
|
Nguyen, Van Anh
|
|
|
13 |
3 |
p. 249-250
|
article
|
| 26 |
Treatment options in early triple-negative breast cancer
|
Suppan, Christoph
|
|
|
13 |
3 |
p. 346-348
|
article
|
Journal description